Atria Wealth Solutions Inc. Sells 1,196 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Atria Wealth Solutions Inc. lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 28.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,060 shares of the company’s stock after selling 1,196 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in HCA Healthcare were worth $1,057,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Capital World Investors boosted its stake in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after acquiring an additional 19,121 shares during the last quarter. Northern Trust Corp lifted its stake in shares of HCA Healthcare by 12.4% during the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company’s stock valued at $605,694,000 after buying an additional 223,248 shares in the last quarter. Nuveen Asset Management LLC lifted its stake in shares of HCA Healthcare by 4.5% during the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company’s stock valued at $560,011,000 after buying an additional 81,105 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of HCA Healthcare by 40,527.3% during the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after buying an additional 1,699,713 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of HCA Healthcare by 12.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,675,460 shares of the company’s stock valued at $502,889,000 after buying an additional 188,093 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on HCA shares. Bank of America cut shares of HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 target price on the stock. in a research note on Wednesday, July 16th. Robert W. Baird reiterated a “neutral” rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Baird R W downgraded shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Stephens upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Finally, JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Nine equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $395.69.

HCA Healthcare Trading Up 0.3%

NYSE HCA opened at $382.90 on Tuesday. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The firm has a market cap of $89.60 billion, a PE ratio of 16.10, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39. The company has a 50 day moving average price of $369.76 and a 200 day moving average price of $350.02. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the business posted $5.50 EPS. HCA Healthcare’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.